| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 12/19/2002 | US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 12/19/2002 | US20020189060 Method for fabricating high purity gold foil |
| 12/19/2002 | DE10128511A1 Treating or preventing atherosclerosis and/or bone metabolism disorders, especially in dialysis patients, using polynuclear metal oxide-modified adsorption material |
| 12/19/2002 | DE10127897A1 Combined pharmaceutical formulation for treating osteoporosis or related disorders, comprising core of dried plant extract enclosed in sheath of calcium salt |
| 12/19/2002 | CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 12/19/2002 | CA2449732A1 Porous sponge-like cellulosic material for treatment of injuries |
| 12/19/2002 | CA2447891A1 Exothermic formulations for the treatment of ectoparasites |
| 12/18/2002 | EP1266666A2 Fibrin sealant compositions and method for utilizing same |
| 12/18/2002 | EP1266654A1 Stabilised amlodipine maleate formulations |
| 12/18/2002 | EP1265637A2 Compositions and methods for affecting osteogenesis |
| 12/18/2002 | EP1265596A2 Medical emulsion for lubrication and delivery of drugs |
| 12/18/2002 | EP0769018B1 Helicobacter proteins and vaccines |
| 12/18/2002 | EP0760668B1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 12/18/2002 | CN1385167A Antimony halide medicine composition for treating leukemia and lymphoma |
| 12/18/2002 | CN1385166A Medicine for treating vertigo |
| 12/18/2002 | CN1385147A Nano calamine and preparation method and use thereof |
| 12/18/2002 | CN1096278C Medicine for treating trigeminal neuralgia |
| 12/18/2002 | CN1096275C External-use Chinese medicine for treating bagy diarrhea |
| 12/17/2002 | US6495579 Administering to a multiple sclerosis patient a therapeutically effective amount of a paclitaxel formulation contining a homo or copopolymer |
| 12/17/2002 | US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis |
| 12/17/2002 | US6495180 Acid reduced whole bean coffee and process |
| 12/17/2002 | US6495153 Anti-fungal composition |
| 12/17/2002 | CA2225808C Silver-based pharmaceutical compositions |
| 12/17/2002 | CA2208110C Ultraviolet-protecting cosmetic compositions containing tio2 nanopigments and an acylaminoacid |
| 12/17/2002 | CA2188688C Use of lanthanide, tin, zinc, manganese, yttrium, cobalt, barium, strontium salt in a skin care composition |
| 12/17/2002 | CA2144398C Composition containing a non photocatalytic metal oxide and tocopherol; use thereof in cosmetic and/or dermatological applications and processes implementing said composition |
| 12/12/2002 | WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 12/12/2002 | WO2002098501A2 Method and apparatus for treating tumors using low strength electric fields |
| 12/12/2002 | WO2002098435A1 Oral compositions for the treatment of obese, non-diabetic mammals, including humans |
| 12/12/2002 | WO2002098416A2 Antineoplastic combinations |
| 12/12/2002 | WO2002098339A2 Zinc containing compositions for anti-viral use |
| 12/12/2002 | WO2002013843A3 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
| 12/12/2002 | WO2002009729A3 Treatment of hyperproliferative skin disorders and diseases |
| 12/12/2002 | US20020187205 Multi-vitamin and mineral supplements for women |
| 12/12/2002 | US20020187204 Diet composition and method of weight management |
| 12/12/2002 | US20020187191 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 12/12/2002 | US20020187184 Method of treating restenosis using bisphosphonate nanoparticles |
| 12/12/2002 | US20020187172 Polymeric material associated with colloidal metal particles, especially gold, suitable for injection or implantation. |
| 12/12/2002 | US20020187134 Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| 12/12/2002 | US20020187102 Novel compositions for use in embolizing blood vessels |
| 12/12/2002 | CA2450009A1 Method and apparatus for treating tumors using low strength electric fields |
| 12/12/2002 | CA2449842A1 Zinc containing compositions for anti-viral use |
| 12/12/2002 | CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 12/12/2002 | CA2447732A1 Antineoplastic combinations |
| 12/12/2002 | CA2447141A1 Oral compositions for the treatment of non-diabetic obese mammals, including humans |
| 12/11/2002 | EP1263482A1 Apparatus and method of treatment of wounds, burns and immune system disorders |
| 12/11/2002 | EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 12/11/2002 | EP1263447A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 12/11/2002 | EP1263440A2 Cephalotaxine alkaloid combination compositions and uses thereof |
| 12/11/2002 | EP1263426A1 Preparations for the non-traumatic excision of a nail |
| 12/11/2002 | EP1263297A1 Diabetic nutritionals |
| 12/11/2002 | EP1175149B1 Disinfecting composition based on h2o2, acids and metal ions |
| 12/11/2002 | EP0942741B1 Lectin compositions and uses thereof |
| 12/11/2002 | CN1384754A Method and composition for treating prostate cancer |
| 12/11/2002 | CN1383883A Chinese medicine for treating pharyngitis and globus hystericus and its prepn |
| 12/11/2002 | CN1383879A Plaster using paper as carrier for treating beriberi |
| 12/11/2002 | CN1383872A Kidney-invigorating and Yang-strenghtening wine |
| 12/11/2002 | CN1383860A Medicine for treating bladder cancer |
| 12/11/2002 | CN1383852A Kidney-strengthening and pregnancy assisting granule |
| 12/10/2002 | US6492429 Apocynin and an inhibitor of inducible nitric oxide synthase |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6492349 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 12/10/2002 | US6492336 Peritoneal dialysis fluid |
| 12/10/2002 | US6491954 Anti-snoring composition |
| 12/10/2002 | US6491946 Potassium iodide, microcrystalline cellulose, hydroxypropyl methylcellulose and/or gelatin as binder; formation of iodine is surprisingly suppressed without antioxidants being present |
| 12/10/2002 | US6491944 Method for making spirillicide |
| 12/10/2002 | CA2244454C Use of nitric monoxide for preparing medication for intravascular administration |
| 12/10/2002 | CA2054268C Nutritional composition |
| 12/05/2002 | WO2002096903A2 Chemical derivatives and the use thereof as an anti-telomerase agent |
| 12/05/2002 | WO2002096447A2 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor |
| 12/05/2002 | WO2002096429A1 Agent for external therapy of psoriasis and method for producing said agent |
| 12/05/2002 | WO2002096413A1 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 12/05/2002 | WO2002096393A1 Anorexic composition comprising calcium acetate |
| 12/05/2002 | WO2002096387A1 Implantable medical device with controllable gaseous agent release system |
| 12/05/2002 | WO2002096353A2 Polymer controlled induced viscosity fiber system and uses thereof |
| 12/05/2002 | WO2002096348A2 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 12/05/2002 | WO2002096223A1 Dual viscosity fiber system and uses thereof |
| 12/05/2002 | WO2002096219A2 Acid controlled viscosity fiber system and uses thereof |
| 12/05/2002 | WO2002096202A1 Antibacterial composition containing an organic acid and copper salt |
| 12/05/2002 | WO2002080854A3 Compositions and methods for the prevention and treatment of human prostate cancer |
| 12/05/2002 | WO2002062397A3 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens |
| 12/05/2002 | WO2002053110A3 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 12/05/2002 | WO2001093909A3 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor |
| 12/05/2002 | WO2001091734A3 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 12/05/2002 | US20020183687 Adhesion prevention and an endoscopic insufflation system therefor |
| 12/05/2002 | US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor |
| 12/05/2002 | US20020183382 For therapy of liver injury resulting from hepatic steatosis or steatohepatitis |
| 12/05/2002 | US20020183380 Administering anti-microtubule compound-containing, pharmaceutically acceptable formulation wherein anti-microtubule compound is paclitaxel for therapy and prophylaxis of surgical adhesions |
| 12/05/2002 | US20020183300 Zinc ionophores as anti-stress agents |
| 12/05/2002 | US20020183288 Administering to a subject suffering from hyperparathyroidism an amount of active vitamin D formula sufficient to lower or maintain lowered blood parathyroid hormone (PTH) levels |
| 12/05/2002 | US20020183280 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye |
| 12/05/2002 | US20020183263 Nutritional preparation comprising ribose and medical use thereof |
| 12/05/2002 | US20020182585 Therapeutic treatment for vascular defects |
| 12/05/2002 | US20020182267 Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 12/05/2002 | US20020182266 Vitamin C, vitamin E, beta-carotene, zinc and copper, preferably in tablet form |
| 12/05/2002 | US20020182265 Lubricious coatings for substrates |
| 12/05/2002 | US20020182264 Mixture of 2 inorganic and 1 organic acids has a pH of less than 1; noncaustic to human tissue; safe for human ingestion; cleansers, pharmaceuticals, food preservatives and disinfectants; medical & industrial applications |
| 12/05/2002 | US20020182263 Pharmaceutical composition comprising dimethylsulfoxide and ozone |
| 12/05/2002 | US20020182262 Based on hypochlorous acid; used in the treatment of leg ulcers or other open wounds. |
| 12/05/2002 | US20020182244 Dietary supplements |